Point72 Asset Management, L.P.
Position in CNTA — Centessa Pharmaceuticals plc
CIK 1603466
STAMFORD, CT
Position in CNTA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
307,355
-71.3% QoQ
Ownership
0.199%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CNTA Over Time
Shares Held
Position Value (USD)
Derivatives in CNTA
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
5,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in CNTA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 307,355 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | — | 5,900 | Call | Defined | 2026-05-15 | |
| 2025-09-30 | — | 1,072,665 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | — | 2,591,596 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | — | 2,286,433 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | — | 3,426,599 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | — | 2,715,663 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | — | 1,762,004 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | — | 2,257,718 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | — | 1,840,482 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | — | 1,840,482 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | — | 2,011,388 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | — | 1,775,482 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | — | 79,700 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | — | 117,800 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | — | 133,600 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | — | 907,000 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | — | 1,097,908 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | — | 302,200 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | — | 100,000 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||